Caxton Associates LP Enovis Corp Transaction History

Caxton Associates LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$44.56 - $62.43 $233,761 - $327,507	5,246 New	5,246 $237,000
Q1 2023 May 15, 2023	BUY	$49.5 - $65.92 $283,041 - $376,930	5,718 Added 25.04%	28,557 $1.53 Million
Q4 2022 Feb 14, 2023	BUY	$44.83 - $57.43 $24,387 - $31,241	544 Added 2.44%	22,839 $1.22 Million
Q3 2022 Nov 14, 2022	BUY	$46.07 - $60.1 $1.03 Million - $1.34 Million	22,295 New	22,295 $1.03 Million

310

60.2M

1.68M

693K

Ticker ENOV
Exchange NYSE
Sector Industrials
Industry Specialty Industrial Machinery
Shares Outstandng 54,129,500
Market Cap $2.38B
Description
Enovis Corporation operates as a medical technology company worldwide. It develops, manufactures, and distributes medical device products used by orthopedic specialists, surgeons, primary care physicians, pain management specialists, physical therapists, podiatrists, chiropractors, athletic trainers, and other healthcare professionals to treat p...

Get notified when there are updates to the investment portfolio of Caxton Associates LP, based on Form 13F filings with the SEC.

Stay updated on Caxton Associates LP with notifications on news.